Soligenix, Inc. (SNGX)
NASDAQ: SNGX · Real-Time Price · USD
1.955
-0.025 (-1.26%)
At close: May 12, 2025, 4:00 PM
1.960
+0.005 (0.26%)
After-hours: May 12, 2025, 6:29 PM EDT
Soligenix Market Cap
Soligenix has a market cap or net worth of $6.17 million as of May 12, 2025. Its market cap has increased by 54.23% in one year.
Market Cap
6.17M
Enterprise Value
-1.19M
1-Year Change
54.23%
Ranking
Category
Stock Price
$1.96
Market Cap Chart
Since December 1, 1998, Soligenix's market cap has decreased from $24.80M to $6.17M, a decrease of -75.12%. That is a compound annual growth rate of -5.12%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 9, 2025 | 6.50M | -4.41% |
Dec 31, 2024 | 6.80M | -13.92% |
Dec 29, 2023 | 7.90M | -59.49% |
Dec 30, 2022 | 19.50M | -31.10% |
Dec 31, 2021 | 28.30M | -25.92% |
Dec 31, 2020 | 38.20M | 27.76% |
Dec 31, 2019 | 29.90M | 96.71% |
Dec 31, 2018 | 15.20M | -21.65% |
Dec 29, 2017 | 19.40M | 128.24% |
Dec 30, 2016 | 8.50M | -72.40% |
Dec 31, 2015 | 30.80M | 42.59% |
Dec 31, 2014 | 21.60M | -37.39% |
Dec 31, 2013 | 34.50M | 414.93% |
Dec 31, 2012 | 6.70M | 1.52% |
Dec 30, 2011 | 6.60M | -83.90% |
Dec 31, 2010 | 41.00M | -11.64% |
Dec 31, 2009 | 46.40M | 660.66% |
Dec 31, 2008 | 6.10M | -62.11% |
Dec 31, 2007 | 16.10M | -2.42% |
Dec 29, 2006 | 16.50M | 20.44% |
Dec 30, 2005 | 13.70M | -49.07% |
Dec 31, 2004 | 26.90M | -0.37% |
Dec 31, 2003 | 27.00M | 167.33% |
Dec 31, 2002 | 10.10M | -22.90% |
Dec 31, 2001 | 13.10M | 3.15% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 659.45B |
Johnson & Johnson | 371.06B |
UnitedHealth Group | 345.29B |
AbbVie | 326.08B |
Novo Nordisk | 297.79B |
Abbott Laboratories | 231.82B |
Novartis AG | 214.71B |
AstraZeneca | 211.14B |